News Conference News ACC 2020 Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT Todd Neale April 02, 2020
News Conference News ACC 2020 Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events Michael O'Riordan April 02, 2020
News Conference News ACC 2020 Evinacumab Cuts LDL Cholesterol in Homozygous FH Yael L. Maxwell April 01, 2020
News Conference News ACC 2020 PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years Michael O'Riordan March 30, 2020
News Conference News ACC 2020 Renal Denervation Lowers BP in Pivotal SPYRAL HTN-OFF MED Trial Todd Neale March 30, 2020
News Conference News ACC 2020 A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA Michael O'Riordan March 28, 2020
News Conference News ACC 2020 Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach Todd Neale March 28, 2020
News Daily News LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure Shelley Wood March 10, 2020
News Conference News CRT 2020 Operator Volume Matters in Left Main PCI: BCIS Analysis Michael O'Riordan March 05, 2020
News Conference News CRT 2020 Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs Michael O'Riordan February 24, 2020
News Daily News FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns Shelley Wood February 14, 2020
News Daily News Outcome Differences Between Men and Women With PAD: EUCLID Insights L.A. McKeown February 11, 2020
News Daily News ‘Super-Dense’ Calcified Plaque Appears Protective Against ACS Michael O'Riordan January 24, 2020
News Daily News Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data Caitlin E. Cox January 20, 2020
News Daily News Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication Michael O'Riordan January 17, 2020
News Daily News Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes Michael O'Riordan January 14, 2020